calpain inhibitor 2 has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bryl, E; Daca, A; Frąckowiak, J; Fulop, T; Hellmann, A; Mikosik, A; Mital, A; Puchalska, Z; Witkowski, JM; Łopatniuk, P | 1 |
1 other study(ies) available for calpain inhibitor 2 and Leukemia, Lymphocytic, Chronic, B-Cell
Article | Year |
---|---|
Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease.
Topics: Aged; Aged, 80 and over; Apoptosis; B-Lymphocytes; Calpain; Case-Control Studies; Caspase 3; Caspase 9; Cells, Cultured; Disease Progression; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Staging; Oligopeptides; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; ZAP-70 Protein-Tyrosine Kinase | 2020 |